Kyle Malady Dexcom Inc (DXCM) insider trading activity
Kyle Malady is Director of DEXCOM INC. Currently has a direct ownership of 22,667 shares of DXCM, which is worth approximately $1.77 Million. The most recent transaction as insider was on Sep 05, 2025, when has been sold 667 shares (Common Stock) at a price of $80.86 per share, resulting in proceeds of $53,933. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
22.7K
2.86%
3M change
24.94%
12M change
Total Value Held
$1.77 Million
Kyle Malady Transaction History
Also insider at
KM
Kyle Malady
Director
New York, NY